B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NLRP3

MOLECULAR TARGET

NLR family pyrin domain containing 3

UniProt: AAI43360NCBI Gene: 11454821 compounds

NLRP3 (NLR family pyrin domain containing 3) is targeted by 21 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NLRP3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Androsterone1.614
2cycloheximide1.614
3Dimethyl Fumarate1.614
4Etiocholanolone1.614
5Hexachlorophene1.614
6Lithocholic Acid1.614
7Niclosamide1.614
8tyrphostin 91.614
9Calcitriol1.393
10Dihydrotestosterone1.393
11Ethinyl Estradiol1.393
12Thioridazine1.393
1320-alpha-Dihydroprogesterone1.102
14Anisomycin1.102
15Chlorhexidine1.102
16oridonin1.102
17Tocainide1.102
18Bortezomib0.691
19Disulfiram0.691
20Glyburide0.691
21Riluzole0.691

About NLRP3 as a Drug Target

NLRP3 (NLR family pyrin domain containing 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 21 compounds with documented NLRP3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NLRP3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.